Bibliographic information
GuidelineUpdated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
Year of Publication2018
Issuing InstitutionWHO
Recommendation
New
A raltegravir (RAL)-based regimen may be recommended as an alternative first-line regimen for infants and children for whom approved dolutegravir (DTG) dosing is not available
Recommended in favor
Conditional
Certainty of evidence
Low